Evaluation of combination chemotherapy in Wistar/Furth rats bearing transplantable Wilms' tumor.
Wistar/Furth rats received chemotherapy with vincristine, actinomycin D and adriamycin alone and in combination following renal subcapsular implantation of a transplantable murine Wilms' tumor and nephrectomy. Each agent prolonged survival significantly compared to control, and both two-drug regimens were superior to single agent therapy. The two-drug programs were equally effective. No drug regimen was effective in preventing abdominal recurrence.